Royalty Pharma plc
RPRX
Rang in aandelen
#893
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a... Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovation in the biopharmaceutical industry in the United States. Its portfolio consists of royalties on approximately 35 marketed therapies and 20 development-stage product candidates that address various therapeutic areas, such as rare disease, oncology, neuroscience, infectious disease, hematology, and diabetes. The company was founded in 1996 and is based in New York, New York.
Aandeelprijs
$60.39
Laatst gesynchroniseerd: 2026-10-19
Marktkapitalisatie
$26.89B
Verandering (1 dag)
-0.93%
Verandering (1 jaar)
64.87%
Land
US
Handel Royalty Pharma plc (RPRX)
Categorie
Healthcare
Dividendgeschiedenis van Royalty Pharma plc (RPRX)
Royalty Pharma plc (aandelsymbool: RPRX) heeft in totaal 23 dividenduitkeringen gedaan.
De som van alle dividenden (aangepast voor aandelensplitsingen) is: $4.50
Dividendrendement (TTM): 0.0157
De som van alle dividenden (aangepast voor aandelensplitsingen) is: $4.50
Dividendrendement (TTM): 0.0157
Dividendbetalingen voor Royalty Pharma plc (RPRX) van 2020 tot 2026
Jaarlijkse dividendbetalingen
| Jaar | Dividend (aangepast voor aandelensplitsingen) | Wijzigen |
|---|---|---|
| 2026 (TTM) | $0.235 | -73.30% |
| 2025 | $0.88 | 4.76% |
| 2024 | $0.84 | 5.00% |
| 2023 | $0.8 | 5.26% |
| 2022 | $0.76 | 11.76% |
| 2021 | $0.68 | 126.67% |
| 2020 | $0.3 | 0.00% |
Lijst van alle dividendbetalingen
| Jaar | Dividend | Wijzigen |
|---|---|---|
| 2026 (TTM) | $0.235 | -73.30% |
| 2025 | $0.88 | 4.76% |
| 2024 | $0.84 | 5.00% |
| 2023 | $0.8 | 5.26% |
| 2022 | $0.76 | 11.76% |
| 2021 | $0.68 | 126.67% |
| 2020 | $0.3 | 0.00% |
Dividendbetalingen voor vergelijkbare bedrijven of concurrenten
| Bedrijf | Aantal dividendbetalingen | Land |
|---|---|---|
| 0.00% |
SE
|
|
| 0.00% |
FR
|
|
| 0.00% |
IT
|
|
| 69.00% |
HK
|
|
| 0.00% |
US
|
